Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis

Journal of Biological Chemistry

Volumn 287, Issue 19, 2012, Pages 15728-15738

  Jules, Joel ^a   Zhang, Ping ^b   Ashley, Jason W ^a   Wei, Shi ^a   Shi, Zhenqi ^a   Liu, Jianzhong ^a   Michalek, Suzanne M ^b   Feng, Xu ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE LOSS; BONE MARROW; CARBONIC ANHYDRASE II; CRITICAL COMPONENT; GENES ENCODING; MOLECULAR BASIS; NUCLEAR FACTOR OF ACTIVATED T-CELLS; NUCLEAR FACTORS; OSTEOCLAST FORMATION; OSTEOCLASTOGENESIS; PATHOLOGICAL CONDITIONS; PRE-TREATMENT; PROINFLAMMATORY CYTOKINES; RECEPTOR ACTIVATOR; SIGNALING PATHWAYS; TARTRATE-RESISTANT ACID PHOSPHATASE; THERAPEUTIC TARGETS; TRANSCRIPTIONAL REGULATOR;

BONE; ENZYME INHIBITION; GENE EXPRESSION; PHOSPHATASES;

GENE EXPRESSION REGULATION;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CARBONATE DEHYDRATASE II; CATHEPSIN K; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MYELOID DIFFERENTIATION FACTOR 88; NUCLEAR FACTOR OF ACTIVATED T CELL CYTOPLASMIC 1; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL LINEAGE; GENE EXPRESSION; GENE EXPRESSION REGULATION; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN MOTIF; UPREGULATION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CELLS, CULTURED; FEMALE; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; INTERLEUKIN-1; MACROPHAGES; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MYELOID DIFFERENTIATION FACTOR 88; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84860851711     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.296228     Document Type: Article

References (45)

1. Dinarello, C. A. (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519-550
2. Pacifici, R. (1998) Cytokines, estrogen, and postmenopausal osteoporosis-the second decade. Endocrinol. 139, 2659-2661
3. Strand, V., and Kavanaugh, A. F. (2004) The role of interleukin-1 in bone resorption in rheumatoid arthritis. Rheumatology 43, iii10-iii16
4. Graves, D. T., and Cochran, D. (2003) The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J. Periodontol. 74, 391-401 (Pubitemid 36939356)
5. Nakamura, I., and Jimi, E. (2006) Regulation of osteoclast differentiation and function by interleukin-1. Vitam. Horm. 74, 357-370
6. Furst, D. E. (2004) Anakinra. Review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin. Ther. 26, 1960-1975
7. Jimi, E., Nakamura, I., Ikebe, T., Akiyama, S., Takahashi, N., and Suda, T. (1998) Activation of NF-κB is involved in the survival of osteoclasts promoted by interleukin-1. J. Biol. Chem. 273, 8799-8805 (Pubitemid 28176159)
8. Jimi, E., Nakamura, I., Duong, L. T., Ikebe, T., Takahashi, N., Rodan, G. A., and Suda, T. (1999) Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp. Cell Res. 247, 84-93 (Pubitemid 29393964)
9. Ma, T., Miyanishi, K., Suen, A., Epstein, N. J., Tomita, T., Smith, R. L., and Goodman, S. B. (2004) Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-α. Cytokine 26, 138-144 (Pubitemid 38596924)
10. Wei, S., Kitaura, H., Zhou, P., Ross, F. P., and Teitelbaum, S. L. (2005) IL-1 mediates TNF-induced osteoclastogenesis. J. Clin. Invest. 115, 282-290 (Pubitemid 40385470)
11. Boyle, W. J., Simonet, W. S., and Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature 423, 337-342 (Pubitemid 40852708)
12. Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., and Galibert, L. (1997) A homologue of the TNF receptor and its ligand enhances T-cell growth and dendritic-cell function. Nature 390, 175-179 (Pubitemid 27507987)
13. Locksley, R. M., Killeen, N., and Lenardo, M. J. (2001) The TNF and TNF receptor superfamilies. Integrating mammalian biology. Cell 104, 487-501 (Pubitemid 32201945)
14. Feng, X. (2005) Regulatory roles and molecular signaling of TNF family members in osteoclasts. Gene 350, 1-13
15. Liu, W., Xu, D., Yang, H., Xu, H., Shi, Z., Cao, X., Takeshita, S., Liu, J., Teale, M., and Feng, X. (2004) Functional identification of three receptor activator of NF-κB cytoplasmic motifs mediating osteoclast differentiation and function. J. Biol. Chem. 279, 54759-54769 (Pubitemid 40053221)
16. Liu, W., Wang, S., Wei, S., Sun, L., and Feng, X. (2005) Receptor activator of NF-κB (RANK) cytoplasmic motif, 369PFQEP373, plays a predominant role in osteoclast survival in part by activating Akt/PKB and its downstream effector AFX/FOXO4. J. Biol. Chem. 280, 43064-43072 (Pubitemid 43049272)
17. 2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol. Rev. 231, 241-256
18. Xu, D., Wang, S., Liu, W., Liu, J., and Feng, X. (2006) A novel receptor activator of NF-κB (RANK) cytoplasmic motif plays an essential role in osteoclastogenesis by committing macrophages to the osteoclast lineage. J. Biol. Chem. 281, 4678-4690 (Pubitemid 43847727)
19. Kim, H., Choi, H. K., Shin, J. H., Kim, K. H., Huh, J. Y., Lee, S. A., Ko, C. Y., Kim, H. S., Shin, H. I., Lee, H. J., Jeong, D., Kim, N., Choi, Y., and Lee, S. Y. (2009) Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J. Clin. Invest. 119, 813-825
20. Beyaert, R., and Fiers, W. (1998) in Cytokines (Mires-Sluis, A., and Thorpe, R., eds) pp. 335-360, Academic Press Limited, San Diego
21. Karmakar, S., Kay, J., and Gravallese, E. M. (2010) Bone damage in rheumatoid arthritis. Mechanistic insights and approaches to prevention. Rheum. Dis. Clin. N. Am. 36, 385-404
22. Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., and Teitelbaum, S. L. (2000) TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106, 1481-1488 (Pubitemid 32038586)
23. Li, P., Schwarz, E. M., O'Keefe, R. J., Ma, L., Boyce, B. F., and Xing, L. (2004) RANK signaling is not required for TNFα-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFα-mediated inflammatory arthritis. J. Bone Miner. Res. 19, 207-213 (Pubitemid 38116734)
24. Jules, J., Shi, Z., Liu, J., Xu, D., Wang, S., and Feng, X. (2010) Receptor activator of NF-κB (RANK) cytoplasmic IVVY535-538 motif plays an essential role in tumor necrosis factor-α (TNF)-mediated osteoclastogenesis. J. Biol. Chem. 285, 37427-37435
25. McHugh, K. P., Hodivala-Dilke, K., Zheng, M. H., Namba, N., Lam, J., Novack, D., Feng, X., Ross, F. P., Hynes, R. O., and Teitelbaum, S. L. (2000) Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105, 433-440 (Pubitemid 30127243)
26. Takeshita, S., Kaji, K., and Kudo, A. (2000) Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res. 15, 1477-1488 (Pubitemid 30484517)
27. Feng, X., Novack, D. V., Faccio, R., Ory, D. S., Aya, K., Boyer, M. I., McHugh, K. P., Ross, F. P., and Teitelbaum, S. L. (2001) A Glanzmann's mutation in β 3 integrin specifically impairs osteoclast function. J. Clin. Invest. 107, 1137-1144 (Pubitemid 32422910)
28. Ory, D. S., Neugeboren, B. A., and Mulligan, R. C. (1996) A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. U.S.A. 93, 11400-11406 (Pubitemid 26347133)
29. Xu, D., Shi, Z., McDonald, J., Pan, G., Cao, X., Yu, X., and Feng, X. (2004) Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members. Biochem. J. 383, 219-225 (Pubitemid 39446682)
30. Unkeless, J. C. (1979) Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150, 580-596
31. Hara, Y., Ukai, T., Yoshimura, A., Shiku, H., and Kato, I. (1998) Histopathological study of the role of CD4- and CD8-positive T cells on bone resorption induced by Escherichia coli endotoxin. Calcif. Tissue Int. 63, 63-66 (Pubitemid 28289936)
32. Kim, J. H., Jin, H. M., Kim, K., Song, I., Youn, B. U., Matsuo, K., and Kim, N. (2009) The mechanism of osteoclast differentiation induced by IL-1. J. Immunol. 183, 1862-1870
33. Cappellen, D., Luong-Nguyen, N. H., Bongiovanni, S., Grenet, O., Wanke, C., and Susa, M. (2002) Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFκ B. J. Biol. Chem. 277, 21971-21982 (Pubitemid 34952352)
34. Heath, J. K., Saklatvala, J., Meikle, M. C., Atkinson, S. J., and Reynolds, J. J. (1985) Pig interleukin 1 (catabolin) is a potent stimulator of bone resorption in vitro. Calcif. Tissue Int. 37, 95-97 (Pubitemid 15102244)
35. Gowen, M., Wood, D. D., and Russell, R. G. (1985) Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity. J. Clin. Invest. 75, 1223-1229 (Pubitemid 15087149)
36. Pacifici, R., Rifas, L., Teitelbaum, S., Slatopolsky, E., McCracken, R., Bergfeld, M., Lee, W., Avioli, L. V., and Peck, W. A. (1987) Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc. Natl. Acad. Sci. U.S.A. 84, 4616-4620 (Pubitemid 17097860)
37. Pacifici, R., Brown, C., Puscheck, E., Friedrich, E., Slatopolsky, E., Maggio, D., McCracken, R., and Avioli, L. V. (1991) Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. U.S.A. 88, 5134-5138 (Pubitemid 21914698)
38. O'Brien, C. A., Gubrij, I., Lin, S. C., Saylors, R. L., and Manolagas, S. C. (1999) STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-κB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone. J. Biol. Chem. 274, 19301-19308
39. Inoue, J., Ishida, T., Tsukamoto, N., Kobayashi, N., Naito, A., Azuma, S., and Yamamoto, T. (2000) Tumor necrosis factor receptor-associated factor (TRAF) family. Adapter proteins that mediate cytokine signaling. Exp. Cell Res. 254, 14-24 (Pubitemid 30066727)
40. Li, J., Sarosi, I., Yan, X. Q., Morony, S., Capparelli, C., Tan, H. L., McCabe, S., Elliott, R., Scully, S., Van, G., Kaufman, S., Juan, S. C., Sun, Y., Tarpley, J., Martin, L., Christensen, K., McCabe, J., Kostenuik, P., Hsu, H., Fletcher, F., Dunstan, C. R., Lacey, D. L., and Boyle, W. J. (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. U.S.A. 97, 1566-1571 (Pubitemid 30118482)
41. Azuma, Y., Kaji, K., Katogi, R., Takeshita, S., and Kudo, A. (2000) Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275, 4858-4864 (Pubitemid 30108878)
42. Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Morinaga, T., Higashio, K., Martin, T. J., and Suda, T. (2000) Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191, 275-286
43. Li, X., Udagawa, N., Itoh, K., Suda, K., Murase, Y., Nishihara, T., Suda, T., and Takahashi, N. (2002) p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143, 3105-3113 (Pubitemid 34809883)
44. Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E. F., Mak, T. W., Kodama, T., and Taniguchi, T. (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901 (Pubitemid 35460788)
45. Matsumoto, M., Kogawa, M., Wada, S., Takayanagi, H., Tsujimoto, M., Katayama, S., Hisatake, K., and Nogi, Y. (2004) Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J. Biol. Chem. 279, 45969-45979 (Pubitemid 39491590)